Nevada 2025 Regular Session

Nevada Assembly Bill AB19

Refer
11/6/24  
Introduced
2/4/25  
Report Pass
4/10/25  
Engrossed
4/15/25  
Refer
4/16/25  
Report Pass
5/19/25  
Enrolled
5/29/25  
Chaptered
6/3/25  

Caption

Revises provisions relating to the Statewide Substance Use Response Working Group. (BDR 40-442)

Summary

AB 19 revises the membership and reporting schedule of Nevada’s Statewide Substance Use Response Working Group, which operates in the Office of the Attorney General. The bill keeps the Working Group focused on coordinating state and local responses to substance misuse and substance use disorders, but expands its membership to include additional perspectives, including the Executive Director of the Department of Indigent Defense Services, a public member with a preference for multilingual households, an emergency response employee, a representative of the Division of Child and Family Services, and a representative of the Nevada District Attorneys Association. It also clarifies that the Department of Health and Human Services designee must come from the Division of Public and Behavioral Health. The bill also changes the annual report deadline from January 31 to August 1, beginning in 2026. That report must continue to include recommendations for establishing, maintaining, expanding, or improving programs addressing substance misuse and substance use disorders, and must be submitted to the Governor, the Attorney General, and legislative recipients depending on the year. The Working Group’s substantive duties remain broad, including prevention, treatment, recovery, overdose response, criminal justice diversion and reentry, data sharing, youth education, and recommendations on controlled-substance prescribing and use of settlement or other designated funds. In practical terms, AB 19 amends NRS 458.460 and NRS 458.480 to broaden the Working Group’s composition and adjust its annual workflow. It affects the Attorney General’s appointment authority, adds new statutory definitions for emergency response employee and related terms, and sets staggered initial terms for the newly added members. The bill does not create a new program or funding source, but it changes how the state’s existing substance-use policy body is structured and when it reports to policymakers. The overall sentiment reflected in the vote history appears supportive, with the bill passing both chambers by comfortable margins. The Assembly approved it 32-10 and the Senate approved it 16-5, suggesting broad bipartisan acceptance of the bill’s administrative and public-health focus. No committee transcript was provided, so there is no recorded discussion here indicating major floor or committee debate. The main point of potential contention is likely the expansion of the Working Group’s membership and the inclusion of additional appointed seats, which can raise questions about representation, balance, and the size of the body. The shift in the reporting deadline may also matter to stakeholders who rely on the annual report for budget or policy planning, though the bill’s text suggests the change is intended to better align reporting with the legislative calendar. Overall, the bill appears to be a technical but policy-relevant update to Nevada’s substance-use response framework.

Impact

AB 19 amends Nevada Revised Statutes 458.460 and 458.480 to expand and refine the Statewide Substance Use Response Working Group, adding new members, clarifying one existing appointment, and changing the annual report deadline from January 31 to August 1. It also establishes initial terms for the newly added members and preserves the Working Group’s existing duties related to prevention, treatment, recovery, overdose response, criminal justice coordination, and recommendations on substance-use funding and policy. The bill primarily affects the Attorney General’s office, the Department of Health and Human Services, the Department of Indigent Defense Services, and the agencies and stakeholders represented on the Working Group.

Sentiment

The bill appears to have been received favorably overall, as reflected by strong final passage votes in both chambers. The Assembly passed it 32-10 and the Senate passed it 16-5, indicating substantial support for the measure’s public-health and coordination goals. Because no committee transcript was provided, there is no direct record here of detailed debate, but the vote margins suggest the bill was generally viewed as a constructive update rather than a controversial policy shift.

Contention

The most likely areas of contention are structural rather than substantive: whether the Working Group should be expanded further, which entities should receive seats, and whether the added members meaningfully improve coordination or simply enlarge the body. The preference for a multilingual public member may also have prompted discussion about representation criteria. The reporting-date change could be debated by those who prefer an earlier annual report for budget and oversight purposes, but the bill text itself does not indicate any major policy disagreement over the Working Group’s core mission.

Companion Bills

No companion bills found.

Previously Filed As

NV SB337

Revises provisions relating to opioids. (BDR 40-204)

NV SB416

Revises provisions relating to the statewide sobriety and drug monitoring program. (BDR 43-423)

NV SB127

Revises provisions relating to certain training for first responders. (BDR 40-30)

NV SB153

Revises provisions relating to certain crimes involving controlled substances. (BDR 40-905)

NV SB192

Revises provisions relating to public health. (BDR 40-86)

NV AB4

Revises provisions relating to public safety. (BDR 15-31)

NV AB64

Revises provisions relating to public meetings. (BDR 19-445)

NV SB457

Revises provisions relating to public safety. (BDR 15-1038)

NV SB495

Revises provisions relating to health care. (BDR 40-1037)

NV AB438

Revises provisions relating to nonemergency medical transportation. (BDR 40-1042)

Similar Bills

CA AB1612

Disposition of controlled substances.

MA H2227

Replacing archaic and stigmatizing language for substance use

US HB830

SAFE Act Save Americans from the Fentanyl Emergency Act

MI HB4948

Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25

NJ S829

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1617

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1203

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.

NJ S2271

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.